Eq: Large Cap

(New York)

Alongside rising rates and yields, accelerating dividends are a nice feature to have right now. The S&P 500’s dividend growth over the last five years has averaged 13.4%. However, every stock on this list has seen growth north of 20%. The five stocks, which come from quite varied sectors, includes UnitedHealth Group, AO Smith, Zoetis, Mastercard, and Nvidia.


FINSUM: The only catch for this group is that dividend yields, on average, are low, with UnitedHealth Group having the highest at 1.4%, well behind the average S&P 500 yield. The advantage, however, is that a stock with strongly rising dividends is more likely to see capital appreciation.

(New York)

The S&P 500 experienced a correction earlier this year, and since February, has been stuck in a rut. While the declines were not terribly deep, the doldrums were very long lasting. In fact, this was the longest correction (without a rebound or a fall into a bear market) since 1984. That meant the market was in correction for 115 straight sessions.


FINSUM: The market has finally regained some momentum, but it feels odd that stocks have been gaining in the face of largely negative trade war news. Then again, stocks love to climb a wall of worry.

(Washington)

The trade war appears to be headed down a poor path ever more quickly, and in response, global stocks are seeing losses. The US is continuing to make threats about ever larger tariffs on its trading partners, and Trump is poised for a tense meeting with European Commission head Juncker in Washington today. The president yesterday referred to tariffs as the “greatest”, and the US put forth a $12 bn support package for American farmers hurt by tariffs.


FINSUM: Stocks don’t know what to do, as this trade war is growing increasingly difficult to handicap. Add to that the uncertain over global central bank policy, and we have a very nervy mix for markets.

Page 55 of 96

Contact Us

Newsletter

Subscribe

Subscribe to our daily newsletter

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…